Heritage Cannabis granted export license for Brazil

Heritage Cannabis Holdings Corp. (CSE: CANN) (OTCQX: HERTF) ("Heritage" or the "Company") announced today that Health Canada has granted Heritage the first license to export cannabis products from Canada to Brazil. In December 2020, Heritage entered into an arrangement (the "Arrangement") with CannaBR Exports Corp. ("CannaBR"), a Brazil-focused CBD pharmaceutical product import and distribution company, for the distribution and bulk sale of formulated CBD products in the Brazilian cannabis market. The arrangement provides for minimum order quantities agreed by both parties to be delivered to CannaBR's large distribution network in Brazil, with the option of entering into long-term distribution agreements. Heritage has partnered with CannaBR to seek and obtain approval from the Brazilian Health Authority (ANVISA) to distribute and sell various formulated CBD products in Brazil and is currently in an advanced stage of product testing to meet the requirements of the Meet ANVISA. Through the partnership in Brazil, CannaBR already has an import license, and since Heritage has obtained the export license from Health Canada, shipping of CBD products will begin within a week to meet ANVISA requirements. Once all the necessary testing requirements have been met, the company will begin final negotiations to enter into a long-term distribution agreement with minimum order quantities. "We are delighted to be the first cannabis company in Canada to receive an export license to Brazil from Health Canada," said Clint Sharples, CEO of Heritage. "Our work with CannaBR is the company's second expansion beyond the Canadian and US markets, and as the Brazilian market is expected to grow dynamically over the next five to seven years, we are poised to take advantage of the many opportunities in the premium Use CBD products. " Heritage is a cannabinoid company focused on the production and sale of products and services based on medicinal and recreational hemp and cannabis. In Canada, Heritage is represented through its subsidiaries Voyage Cannabis Corp. and CannaCure Corp. operating, both of which are regulated under the provisions of the Cannabis Act. Among these subsidiaries and the brands Purefarma, Pura Vida, Premium 5, RAD and feelgood. Heritage focuses on the extraction and manufacture of derivative products for recreational users and the formulation of medicinal cannabis-based solutions. In the US, Heritage operates under Opticann Inc., a Colorado-based oral and topical cannabinoids company with the exclusive rights to distribute CBD and CBG products using the patented VESIsorb® drug delivery system for optimized absorption and stability can be established. As the parent company, Heritage focuses on providing the resources for its subsidiaries to further develop their products or services in order to be competitive both domestically and internationally.